Media coverage
3
Media coverage
Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients Media name/outlet PipelineReview Country/Territory Spain Date 9/01/20 URL www.pipelinereview.com/index.php/2020010973482/Antibodies/Oxford-BioTherapeutics-Initiates-Dose-Escalation-Portion-of-U.S.-Phase-I-Clinical-Trial-for-OBT076-in-Patients.html Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of Phase I Clinical Trial Media name/outlet Drug Development & Delivery Country/Territory United States Date 9/01/20 URL https://drug-dev.com/oxford-biotherapeutics-initiates-dose-escalation-portion-of-phase-i-clinical-trial/ Persons Gary Schwartz Title Oxford BioTherapeutics Initiates Dose-Escalation Portion of U.S. Phase I Clinical Trial for OBT076 in Patients with Advanced Solid Tumors Media name/outlet Catapult Country/Territory United Kingdom Date 9/01/20 URL www.catapult-ventures.com/news/oxford-biotherapeutics-initiates-dose-escalation-portion-of-us-phase-i-clinical-trial-for-obt076-in-patients-with-advanced-solid-tumors Persons Gary Schwartz